BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer

Concurrent/adjuvant cisplatin-based chemoradiotherapy is regarded as the standard of treatment for locoregionally advanced nasopharyngeal carcinoma (NPC). However, patients who do not respond to cisplatin suffer, rather than benefit, from chemotherapy treatment. The goal of this study was to identif...

Full description

Saved in:
Bibliographic Details
Published in:Cell Death Dis
Main Authors: Kuang, Chun-mei, Fu, Xiang, Hua, Yi-jun, Shuai, Wen-di, Ye, Zhi-hua, Li, Yingchang, Peng, Qi-hua, Li, Yi-zhuo, Chen, Shuai, Qian, Chao-nan, Huang, Wenlin, Liu, Ran-yi
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2017
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520926/
https://ncbi.nlm.nih.gov/pubmed/28617432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.271
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items